Identification of GPX4 as a therapeutic target for lung adenocarcinoma after EGFR-TKI resistance
Identification of GPX4 as a therapeutic target for lung adenocarcinoma after EGFR-TKI resistance is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Identification of GPX4 as a therapeutic target for lung adenocarcinoma after EGFR-TKI resistance have?
Identification of GPX4 as a therapeutic target for lung adenocarcinoma after EGFR-TKI resistance has 31 citations in the OpenAlex counts ScholarIQ stores.
When was Identification of GPX4 as a therapeutic target for lung adenocarcinoma after EGFR-TKI resistance published?
Identification of GPX4 as a therapeutic target for lung adenocarcinoma after EGFR-TKI resistance has 2022 year in the ScholarIQ index.
What is the open-access status of Identification of GPX4 as a therapeutic target for lung adenocarcinoma after EGFR-TKI resistance?
Identification of GPX4 as a therapeutic target for lung adenocarcinoma after EGFR-TKI resistance has diamond oa status in the ScholarIQ index.
What is the DOI of Identification of GPX4 as a therapeutic target for lung adenocarcinoma after EGFR-TKI resistance?
The DOI for Identification of GPX4 as a therapeutic target for lung adenocarcinoma after EGFR-TKI resistance is on the source record.
What is the PMID of Identification of GPX4 as a therapeutic target for lung adenocarcinoma after EGFR-TKI resistance?
The PMID for Identification of GPX4 as a therapeutic target for lung adenocarcinoma after EGFR-TKI resistance is on the source record.
What is the OpenAlex record for Identification of GPX4 as a therapeutic target for lung adenocarcinoma after EGFR-TKI resistance?
The OpenAlex for Identification of GPX4 as a therapeutic target for lung adenocarcinoma after EGFR-TKI resistance is on the source record.